Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts.
Saved in:
| Title: | Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts. |
|---|---|
| Authors: | Fastner S; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Shen N; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, USA., Hartman RI; Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, VA Integrated Service Network (VISN-1), Jamaica Plain, Massachusetts, USA., Chu EY; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kim CC; Department of Dermatology, Tufts Medical Center, Boston, Massachusetts, USA., Kirkwood JM; Departments of Dermatology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.; Departments of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Grossman D; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.; Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA. |
| Source: | Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 22103-22108. Date of Electronic Publication: 2023 Dec 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
